StockNews.com assumed coverage on shares of Stericycle (NASDAQ:SRCL – Free Report) in a report released on Sunday morning. The brokerage issued a hold rating on the business services provider’s stock.
Other equities analysts have also issued research reports about the company. Truist Financial upped their price objective on Stericycle from $50.00 to $62.00 and gave the stock a hold rating in a research note on Tuesday, June 4th. Royal Bank of Canada restated a sector perform rating and issued a $62.00 price target (down from $69.00) on shares of Stericycle in a research note on Tuesday, June 4th. Finally, Keefe, Bruyette & Woods lifted their price objective on shares of Stericycle from $135.00 to $142.00 and gave the company an outperform rating in a research report on Tuesday, June 4th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of Hold and an average price target of $74.00.
View Our Latest Stock Analysis on SRCL
Stericycle Trading Up 0.4 %
Stericycle (NASDAQ:SRCL – Get Free Report) last released its earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.57 by $0.04. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. The company had revenue of $661.60 million for the quarter, compared to analysts’ expectations of $672.07 million. As a group, research analysts predict that Stericycle will post 2.29 earnings per share for the current year.
Hedge Funds Weigh In On Stericycle
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of Stericycle by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 8,969,118 shares of the business services provider’s stock valued at $444,509,000 after purchasing an additional 52,576 shares in the last quarter. Capital Research Global Investors increased its holdings in shares of Stericycle by 11.4% in the 1st quarter. Capital Research Global Investors now owns 6,667,911 shares of the business services provider’s stock worth $351,732,000 after buying an additional 679,974 shares during the last quarter. Earnest Partners LLC raised its position in shares of Stericycle by 12.4% during the 1st quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider’s stock valued at $129,766,000 after buying an additional 271,025 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Stericycle by 7.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,171,659 shares of the business services provider’s stock valued at $126,238,000 after acquiring an additional 142,814 shares during the last quarter. Finally, Schroder Investment Management Group grew its position in Stericycle by 8.1% in the fourth quarter. Schroder Investment Management Group now owns 1,739,644 shares of the business services provider’s stock worth $86,217,000 after acquiring an additional 129,822 shares in the last quarter. 98.82% of the stock is owned by institutional investors.
About Stericycle
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
Recommended Stories
- Five stocks we like better than Stericycle
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Don’t Overlook Campbell Soup: Here’s What Could Drive Its Stock
- Where Do I Find 52-Week Highs and Lows?
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Why Dell Can Continue Winning in AI and Beyond
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.